Cabaletta Bio, Inc. (CABA)
3.51
+0.11
(+3.24%)
USD |
NASDAQ |
Apr 16, 15:14
Cabaletta Bio Market Cap : 390.74M for April 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anavex Life Sciences Corp. | 312.30M |
| ACADIA Pharmaceuticals, Inc. | 3.623B |
| Alnylam Pharmaceuticals, Inc. | 42.76B |
| Savara, Inc. | 1.167B |
| BioMarin Pharmaceutical, Inc. | 10.39B |
Market Cap Related Metrics
| Price to Book Value | 3.487 |
| Price | 3.51 |
| Earnings Yield | -65.34% |